{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T18:31:58Z","timestamp":1767205918175,"version":"build-2238731810"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p>This study aimed to investigate the protective effect of Xinmailong injection on rats with myocardial infarction. Thirty-six rats were induced myocardial infarction by operation, and six underwent sham operation. The myocardial infarction rats were randomly divided into three groups, 12 in each, and administered intraperitoneal injection of Xinmailong 5 mg\/(kg\u00b7d), sodium creatine phosphate 80 mg\/(kg\u00b7d), or normal saline as control respectively for 14 days. When the treatments were completed, the hemodynamic parameters of the rats were observed, and blood samples were taken to examine blood routine, blood coagulation index, liver and kidney function, inflammatory index, myocardial marker, thrombo-elastography, and other indicators. The morphology of cardiomyocytes was observed through light microscopy, and the microstructure of the myocardial cells was observed under electron microscope. No significant difference was found in blood routine, liver and kidney function, and blood coagulation index between the Xinmailong and sodium creatine phosphate groups compared with the saline control group. However, the inflammatory index and levels of myocardial markers were significantly decreased, and cardiac function was significantly improved. In terms of the morphology of myocardial cells, the Xinmailong group was similar to the sodium creatine phosphate group, the myocardial cell membrane was protected, and myocardial cell damage was reduced. In conclusion, Xinmailong is safe and had anti-inflammatory, heart-improving, and myocardial-protective effects. Its effectiveness is not inferior to that of sodium creatine phosphate.<\/jats:p>","DOI":"10.3389\/fphys.2020.595760","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T03:12:51Z","timestamp":1610593971000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["RETRACTED: Protective Effect of Xinmailong Injection on Rats With Myocardial Infarction"],"prefix":"10.3389","volume":"11","author":[{"given":"Wei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kailiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiefeng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quanjin","family":"Si","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,13]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e0208038","DOI":"10.1371\/journal.pone.0208038","article-title":"Role of CTRP3, CTRP9 and MCP-1 for the evaluation of T2DM associated coronary artery disease in Egyptian postmenopausal females","volume":"13","author":"Ahmed","year":"2018","journal-title":"PLoS One"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1136\/heart.84.1.93","article-title":"Coronary disease. Acute coronary syndromes: presentation\u2014clinical spectrum and management","volume":"84","author":"Fox","year":"2000","journal-title":"Heart"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"246","DOI":"10.11909\/j.issn.1671-5411.2020.05.008","article-title":"Long-term follow-up of antithrombotic management patterns in patients with acute coronary syndrome in China","volume":"17","author":"Han","year":"2020","journal-title":"J. Geriatr. Cardiol."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/978-3-319-40827-9_31","article-title":"Computational study of aortic hemodynamics: from simplified to patient-specific geometries","volume-title":"Advances in computational fluid-structure interaction and flow simulation","author":"Lefieux","year":"2016"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.14148\/j.issn.1672-0482.2018.0185","article-title":"Effect of humidified oxygen therapy with xiexiang formula on myocardial injury markers and pathological morphology of cardiopulmonary tissue of mice with myocardial infarction","volume":"34","author":"Lin","year":"2018","journal-title":"J. Nanjing Univ. Tradit. Chin. Med."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1001\/jamacardio.2019.0295","article-title":"Burden of cardiovascular diseases in China, 1990\u20132016: findings from the 2016 global burden of disease study","volume":"4","author":"Liu","year":"2019","journal-title":"JAMA Cardiol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"810","DOI":"10.3389\/fphar.2018.00810","article-title":"Clinical efficacy and safety of Xinmailong injection for the treatment of chronic heart failure: a meta-analysis","volume":"9","author":"Lu","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e0128655","DOI":"10.1371\/journal.pone.0128655","article-title":"1,25 Dihydroxyvitamin D3 inhibits TGFbeta1-mediated primary human cardiac myofibroblast activation","volume":"10","author":"Meredith","year":"2015","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/bs.acc.2017.12.002","article-title":"Inflammatory response during myocardial infarction","volume":"84","author":"Oliveira","year":"2018","journal-title":"Adv. Clin. Chem."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"42843","DOI":"10.1038\/srep42843","article-title":"Mechanisms of Chinese medicine Xinmailong\u2019s protection against heart failure in pressure-overloaded mice and cultured cardiomyocytes","volume":"7","author":"Qi","year":"2017","journal-title":"Sci. Rep."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.amjmed.2016.09.014","article-title":"Trends in incidence of hospitalized acute myocardial infarction in the cardiovascular research network (CVRN)","volume":"130","author":"Reynolds","year":"2017","journal-title":"Am. J. Med."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2017.04.052","article-title":"Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015","volume":"70","author":"Roth","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref13","first-page":"461","article-title":"Cardiovascular action and therapeutic effect of Xinmailong injection for treating heart failure","volume":"17","author":"Tang","year":"2008","journal-title":"Chinese J. New Drug"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e0144523","DOI":"10.1371\/journal.pone.0144523","article-title":"Widespread myocardial delivery of heart-derived stem cells by nonocclusive triple-vessel intracoronary infusion in porcine ischemic cardiomyopathy: superior attenuation of adverse remodeling documented by magnetic resonance imaging and histology","volume":"11","author":"Tseliou","year":"2016","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.13286\/j.cnki.chinhosppharmacyj.2017.12.15","article-title":"Effects of antioxi-dant therapy on prevention and trearment of ventricular re-modeling in patients with acute myocardial infarction","volume":"37","author":"Wang","year":"2017","journal-title":"Chin. Hosp. Pharm. J."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3389\/fphar.2019.00923","article-title":"Xinmailong modulates platelet function and inhibits thrombus formation via the platelet alphaIIbbeta3-mediated signaling pathway","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Pharmacol."}],"updated-by":[{"DOI":"10.3389\/fphys.2022.1006572","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T00:00:00Z","timestamp":1659571200000},"record-id":"38642"},{"DOI":"10.3389\/fphys.2022.1006572","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T00:00:00Z","timestamp":1659571200000}}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2020.595760\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T12:38:48Z","timestamp":1712925528000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2020.595760\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,13]]},"references-count":16,"alternative-id":["10.3389\/fphys.2020.595760"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2020.595760","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,13]]},"article-number":"595760"}}